img

Global Rotavirus Infections Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rotavirus Infections Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rotavirus Infections Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rotavirus Infections Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rotavirus Infections Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Rotavirus Infections Drug key manufacturers include Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Biological E Ltd, Curevac AG, Medicago Inc, Nanotherapeutics Inc, Serum Institute of India Ltd, UMN Pharma Inc and Wuhan Institute of Biological Products Co Ltd, etc. Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Biological E Ltd are top 3 players and held % sales share in total in 2022.
Rotavirus Infections Drug can be divided into RV-3BB, RV-625, UMN-2001 and Rotavac-5C, etc. RV-3BB is the mainstream product in the market, accounting for % sales share globally in 2022.
Rotavirus Infections Drug is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Rotavirus Infections Drug industry development. In 2022, global % sales of Rotavirus Infections Drug went into Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rotavirus Infections Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
Curevac AG
Medicago Inc
Nanotherapeutics Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Institute of Biological Products Co Ltd
Segment by Type
RV-3BB
RV-625
UMN-2001
Rotavac-5C
Others

Segment by Application


Clinic
Hospital
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rotavirus Infections Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rotavirus Infections Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rotavirus Infections Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rotavirus Infections Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rotavirus Infections Drug introduction, etc. Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Rotavirus Infections Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Rotavirus Infections Drug Market Overview
1.1 Rotavirus Infections Drug Product Overview
1.2 Rotavirus Infections Drug Market Segment by Type
1.2.1 RV-3BB
1.2.2 RV-625
1.2.3 UMN-2001
1.2.4 Rotavac-5C
1.2.5 Others
1.3 Global Rotavirus Infections Drug Market Size by Type
1.3.1 Global Rotavirus Infections Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Rotavirus Infections Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Rotavirus Infections Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rotavirus Infections Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Rotavirus Infections Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Rotavirus Infections Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Rotavirus Infections Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Rotavirus Infections Drug Sales Breakdown by Type (2018-2024)
2 Global Rotavirus Infections Drug Market Competition by Company
2.1 Global Top Players by Rotavirus Infections Drug Sales (2018-2024)
2.2 Global Top Players by Rotavirus Infections Drug Revenue (2018-2024)
2.3 Global Top Players by Rotavirus Infections Drug Price (2018-2024)
2.4 Global Top Manufacturers Rotavirus Infections Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rotavirus Infections Drug Market Competitive Situation and Trends
2.5.1 Rotavirus Infections Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rotavirus Infections Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rotavirus Infections Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Rotavirus Infections Drug Market
2.8 Key Manufacturers Rotavirus Infections Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rotavirus Infections Drug Status and Outlook by Region
3.1 Global Rotavirus Infections Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Rotavirus Infections Drug Historic Market Size by Region
3.2.1 Global Rotavirus Infections Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Rotavirus Infections Drug Sales in Value by Region (2018-2024)
3.2.3 Global Rotavirus Infections Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Rotavirus Infections Drug Forecasted Market Size by Region
3.3.1 Global Rotavirus Infections Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Rotavirus Infections Drug Sales in Value by Region (2024-2034)
3.3.3 Global Rotavirus Infections Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Rotavirus Infections Drug by Application
4.1 Rotavirus Infections Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Others
4.2 Global Rotavirus Infections Drug Market Size by Application
4.2.1 Global Rotavirus Infections Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Rotavirus Infections Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Rotavirus Infections Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rotavirus Infections Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Rotavirus Infections Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Rotavirus Infections Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Rotavirus Infections Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Rotavirus Infections Drug Sales Breakdown by Application (2018-2024)
5 North America Rotavirus Infections Drug by Country
5.1 North America Rotavirus Infections Drug Historic Market Size by Country
5.1.1 North America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Rotavirus Infections Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Rotavirus Infections Drug Sales in Value by Country (2018-2024)
5.2 North America Rotavirus Infections Drug Forecasted Market Size by Country
5.2.1 North America Rotavirus Infections Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Rotavirus Infections Drug Sales in Value by Country (2024-2034)
6 Europe Rotavirus Infections Drug by Country
6.1 Europe Rotavirus Infections Drug Historic Market Size by Country
6.1.1 Europe Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Rotavirus Infections Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Rotavirus Infections Drug Sales in Value by Country (2018-2024)
6.2 Europe Rotavirus Infections Drug Forecasted Market Size by Country
6.2.1 Europe Rotavirus Infections Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Rotavirus Infections Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Rotavirus Infections Drug by Region
7.1 Asia-Pacific Rotavirus Infections Drug Historic Market Size by Region
7.1.1 Asia-Pacific Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Rotavirus Infections Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Rotavirus Infections Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Rotavirus Infections Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Rotavirus Infections Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Rotavirus Infections Drug Sales in Value by Region (2024-2034)
8 Latin America Rotavirus Infections Drug by Country
8.1 Latin America Rotavirus Infections Drug Historic Market Size by Country
8.1.1 Latin America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Rotavirus Infections Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Rotavirus Infections Drug Sales in Value by Country (2018-2024)
8.2 Latin America Rotavirus Infections Drug Forecasted Market Size by Country
8.2.1 Latin America Rotavirus Infections Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Rotavirus Infections Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Rotavirus Infections Drug by Country
9.1 Middle East and Africa Rotavirus Infections Drug Historic Market Size by Country
9.1.1 Middle East and Africa Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Rotavirus Infections Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Rotavirus Infections Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Rotavirus Infections Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Rotavirus Infections Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Rotavirus Infections Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Beijing Minhai Biotechnology Co Ltd
10.1.1 Beijing Minhai Biotechnology Co Ltd Company Information
10.1.2 Beijing Minhai Biotechnology Co Ltd Introduction and Business Overview
10.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Products Offered
10.1.5 Beijing Minhai Biotechnology Co Ltd Recent Development
10.2 Bharat Biotech International Ltd
10.2.1 Bharat Biotech International Ltd Company Information
10.2.2 Bharat Biotech International Ltd Introduction and Business Overview
10.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bharat Biotech International Ltd Rotavirus Infections Drug Products Offered
10.2.5 Bharat Biotech International Ltd Recent Development
10.3 Biological E Ltd
10.3.1 Biological E Ltd Company Information
10.3.2 Biological E Ltd Introduction and Business Overview
10.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biological E Ltd Rotavirus Infections Drug Products Offered
10.3.5 Biological E Ltd Recent Development
10.4 Curevac AG
10.4.1 Curevac AG Company Information
10.4.2 Curevac AG Introduction and Business Overview
10.4.3 Curevac AG Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Curevac AG Rotavirus Infections Drug Products Offered
10.4.5 Curevac AG Recent Development
10.5 Medicago Inc
10.5.1 Medicago Inc Company Information
10.5.2 Medicago Inc Introduction and Business Overview
10.5.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Medicago Inc Rotavirus Infections Drug Products Offered
10.5.5 Medicago Inc Recent Development
10.6 Nanotherapeutics Inc
10.6.1 Nanotherapeutics Inc Company Information
10.6.2 Nanotherapeutics Inc Introduction and Business Overview
10.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Nanotherapeutics Inc Rotavirus Infections Drug Products Offered
10.6.5 Nanotherapeutics Inc Recent Development
10.7 Serum Institute of India Ltd
10.7.1 Serum Institute of India Ltd Company Information
10.7.2 Serum Institute of India Ltd Introduction and Business Overview
10.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Serum Institute of India Ltd Rotavirus Infections Drug Products Offered
10.7.5 Serum Institute of India Ltd Recent Development
10.8 UMN Pharma Inc
10.8.1 UMN Pharma Inc Company Information
10.8.2 UMN Pharma Inc Introduction and Business Overview
10.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 UMN Pharma Inc Rotavirus Infections Drug Products Offered
10.8.5 UMN Pharma Inc Recent Development
10.9 Wuhan Institute of Biological Products Co Ltd
10.9.1 Wuhan Institute of Biological Products Co Ltd Company Information
10.9.2 Wuhan Institute of Biological Products Co Ltd Introduction and Business Overview
10.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Products Offered
10.9.5 Wuhan Institute of Biological Products Co Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rotavirus Infections Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rotavirus Infections Drug Industrial Chain Analysis
11.4 Rotavirus Infections Drug Market Dynamics
11.4.1 Rotavirus Infections Drug Industry Trends
11.4.2 Rotavirus Infections Drug Market Drivers
11.4.3 Rotavirus Infections Drug Market Challenges
11.4.4 Rotavirus Infections Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rotavirus Infections Drug Distributors
12.3 Rotavirus Infections Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of RV-3BB
Table 2. Major Company of RV-625
Table 3. Major Company of UMN-2001
Table 4. Major Company of Rotavac-5C
Table 5. Major Company of Others
Table 6. Global Rotavirus Infections Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Rotavirus Infections Drug Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Rotavirus Infections Drug Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Rotavirus Infections Drug Sales by Type (2018-2024) & (US& Million)
Table 10. Global Rotavirus Infections Drug Market Share in Value by Type (2018-2024)
Table 11. Global Rotavirus Infections Drug Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Rotavirus Infections Drug Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Rotavirus Infections Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Rotavirus Infections Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Rotavirus Infections Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Rotavirus Infections Drug Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Rotavirus Infections Drug Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Rotavirus Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Rotavirus Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Rotavirus Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Rotavirus Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Rotavirus Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Rotavirus Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Rotavirus Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Rotavirus Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Rotavirus Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Rotavirus Infections Drug Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Rotavirus Infections Drug Sales Share by Company (2018-2024)
Table 29. Global Rotavirus Infections Drug Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Rotavirus Infections Drug Revenue Share by Company (2018-2024)
Table 31. Global Market Rotavirus Infections Drug Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Rotavirus Infections Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Rotavirus Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rotavirus Infections Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Rotavirus Infections Drug Market
Table 36. Key Manufacturers Rotavirus Infections Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Rotavirus Infections Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Rotavirus Infections Drug Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Rotavirus Infections Drug Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Rotavirus Infections Drug Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Rotavirus Infections Drug Sales Market Share in Value by Region (2018-2024)
Table 43. Global Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Rotavirus Infections Drug Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Rotavirus Infections Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Rotavirus Infections Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Rotavirus Infections Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Rotavirus Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Rotavirus Infections Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Rotavirus Infections Drug Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Rotavirus Infections Drug Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Rotavirus Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Rotavirus Infections Drug Sales Market Share in Value by Application (2018-2024)
Table 54. Global Rotavirus Infections Drug Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Rotavirus Infections Drug Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Rotavirus Infections Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Rotavirus Infections Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Rotavirus Infections Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Rotavirus Infections Drug Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Rotavirus Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 61. North America Rotavirus Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Rotavirus Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Rotavirus Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Rotavirus Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Rotavirus Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Rotavirus Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Rotavirus Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Rotavirus Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Rotavirus Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Rotavirus Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Rotavirus Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Rotavirus Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Rotavirus Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 74. North America Rotavirus Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Rotavirus Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Rotavirus Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Rotavirus Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Rotavirus Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Rotavirus Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Rotavirus Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Rotavirus Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Rotavirus Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Rotavirus Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Rotavirus Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Rotavirus Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Rotavirus Infections Drug Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Rotavirus Infections Drug Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Rotavirus Infections Drug Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Rotavirus Infections Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Rotavirus Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Rotavirus Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Rotavirus Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Rotavirus Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Rotavirus Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Rotavirus Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Rotavirus Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Rotavirus Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Rotavirus Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Rotavirus Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Rotavirus Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Rotavirus Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Beijing Minhai Biotechnology Co Ltd Company Information
Table 111. Beijing Minhai Biotechnology Co Ltd Introduction and Business Overview
Table 112. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product
Table 114. Beijing Minhai Biotechnology Co Ltd Recent Development
Table 115. Bharat Biotech International Ltd Company Information
Table 116. Bharat Biotech International Ltd Introduction and Business Overview
Table 117. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Bharat Biotech International Ltd Rotavirus Infections Drug Product
Table 119. Bharat Biotech International Ltd Recent Development
Table 120. Biological E Ltd Company Information
Table 121. Biological E Ltd Introduction and Business Overview
Table 122. Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Biological E Ltd Rotavirus Infections Drug Product
Table 124. Biological E Ltd Recent Development
Table 125. Curevac AG Company Information
Table 126. Curevac AG Introduction and Business Overview
Table 127. Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Curevac AG Rotavirus Infections Drug Product
Table 129. Curevac AG Recent Development
Table 130. Medicago Inc Company Information
Table 131. Medicago Inc Introduction and Business Overview
Table 132. Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Medicago Inc Rotavirus Infections Drug Product
Table 134. Medicago Inc Recent Development
Table 135. Nanotherapeutics Inc Company Information
Table 136. Nanotherapeutics Inc Introduction and Business Overview
Table 137. Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Nanotherapeutics Inc Rotavirus Infections Drug Product
Table 139. Nanotherapeutics Inc Recent Development
Table 140. Serum Institute of India Ltd Company Information
Table 141. Serum Institute of India Ltd Introduction and Business Overview
Table 142. Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Serum Institute of India Ltd Rotavirus Infections Drug Product
Table 144. Serum Institute of India Ltd Recent Development
Table 145. UMN Pharma Inc Company Information
Table 146. UMN Pharma Inc Introduction and Business Overview
Table 147. UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. UMN Pharma Inc Rotavirus Infections Drug Product
Table 149. UMN Pharma Inc Recent Development
Table 150. Wuhan Institute of Biological Products Co Ltd Company Information
Table 151. Wuhan Institute of Biological Products Co Ltd Introduction and Business Overview
Table 152. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product
Table 154. Wuhan Institute of Biological Products Co Ltd Recent Development
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Rotavirus Infections Drug Market Trends
Table 158. Rotavirus Infections Drug Market Drivers
Table 159. Rotavirus Infections Drug Market Challenges
Table 160. Rotavirus Infections Drug Market Restraints
Table 161. Rotavirus Infections Drug Distributors List
Table 162. Rotavirus Infections Drug Downstream Customers
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Rotavirus Infections Drug Product Picture
Figure 2. Global Rotavirus Infections Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Rotavirus Infections Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Rotavirus Infections Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of RV-3BB
Figure 6. Global RV-3BB Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of RV-625
Figure 8. Global RV-625 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of UMN-2001
Figure 10. Global UMN-2001 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Rotavac-5C
Figure 12. Global Rotavac-5C Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Rotavirus Infections Drug Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Rotavirus Infections Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Rotavirus Infections Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Rotavirus Infections Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Rotavirus Infections Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Rotavirus Infections Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Rotavirus Infections Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Rotavirus Infections Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Rotavirus Infections Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Rotavirus Infections Drug Revenue in 2022
Figure 29. Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Rotavirus Infections Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Rotavirus Infections Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Rotavirus Infections Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Rotavirus Infections Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Rotavirus Infections Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Rotavirus Infections Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Rotavirus Infections Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Rotavirus Infections Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Rotavirus Infections Drug Manufacturing Cost Structure
Figure 49. Rotavirus Infections Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries